May 09, 2016 Both warfarin and atrial fibrillation may raise risk FRIDAY, May 6, 2016 (HealthDay News) — Patients with atrial fibrillation may have a heightened risk of developing dementia — and the quality of their anticoagulation treatment may play a role, according to findings presented at the annual meeting of the Heart Rhythm Society, […]
Clinical Pain Medicine ISSUE: JULY 2015 | VOLUME: 13(7) Taking a nonsteroidal anti-inflammatory drug (NSAID) with antithrombotic therapy after a myocardial infarction (MI) almost doubles the risk for bleeding compared with not using NSAIDs—even after short-term treatment, according to a study published in the Journal of the American Medical Association (2015;313:805-814). The cardiovascular event risk […]
Research · April 14, 2014 TAKE-HOME MESSAGE This study estimated the bleeding risk when the use of anticoagulant therapy (rivaroxaban or enoxaparin–vitamin K antagonist) was combined with either an NSAID or aspirin therapy in patients with VTE enrolled in clinical trials from 2007 to 2009. Clinically relevant bleeding was higher with combined use compared with anticoagulant use […]
Devada Singh-Franco, PharmD December 26, 2013 Question How common is upper gastrointestinal injury associated with the newer oral antiplatelet agents and anticoagulants? Between 1998 and 2005, more than 1.4 million hospitalizations were the result of peptic ulcer disease, with an average age-adjusted hospitalization rate of 63.6 per 100,000 population.[1] Age was a factor: The estimated […]
12.20.2013 by Todd Neale Senior Staff Writer, MedPage Today Starting warfarin for preventing stroke in patients with atrial fibrillation appeared to be associated with a transiently increased risk of ischemic stroke before the preventive effects kicked in, a large case-control study showed. Compared with not taking any antithrombotics, initiating warfarin was associated with a greater […]